Review





Similar Products

96
OriGene nontargeting shrna vector
Nontargeting Shrna Vector, supplied by OriGene, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/Scrambled+shRNA+control+in+pGFP-C-shLenti+shRNA+Vector/pm42975681-30-17-21
Average 96 stars, based on 1 article reviews
nontargeting shrna vector - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology nontargeting control shrna lentiviruses
Nontargeting Control Shrna Lentiviruses, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/Control+shRNA+Lentiviral+Particles-A/10__1038_slash_s42003___026___10993___4-462-16-20
Average 96 stars, based on 1 article reviews
nontargeting control shrna lentiviruses - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

86
Sangon Biotech nontargeting scramble sirna
Nontargeting Scramble Sirna, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/scramble+sirna/pm42072428-130-11-22
Average 86 stars, based on 1 article reviews
nontargeting scramble sirna - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Shanghai Genechem Ltd nontargeting scrambled negative control short hairpin rna shnc
Nontargeting Scrambled Negative Control Short Hairpin Rna Shnc, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/control+lentivirus+negative/pmc13265161-79-14-32
Average 86 stars, based on 1 article reviews
nontargeting scrambled negative control short hairpin rna shnc - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology nontargeting scrambled shrna
Nontargeting Scrambled Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/Control+shRNA+Plasmid-A/pm41816749-57-1-6
Average 96 stars, based on 1 article reviews
nontargeting scrambled shrna - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

86
Genechem shrna nontarget control
Shrna Nontarget Control, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/control+nontarget+shrna/pmc12968730-145-29-37
Average 86 stars, based on 1 article reviews
shrna nontarget control - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology nontargeting shrna control
Nontargeting Shrna Control, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/Control+shRNA+Lentiviral+Particles-A/pm41699318-344-1-4
Average 96 stars, based on 1 article reviews
nontargeting shrna control - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

86
Genechem nontargeting shrna control sh nc
Nontargeting Shrna Control Sh Nc, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/control+non+targeting/pm41689713-59-14-23
Average 86 stars, based on 1 article reviews
nontargeting shrna control sh nc - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology nontargeted shctrl
Nontargeted Shctrl, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/Control+shRNA+Plasmid-A/pm41671087-431-72-75
Average 96 stars, based on 1 article reviews
nontargeted shctrl - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology control nontargeting shrna plasmid
Preproghrelin, and thus obestatin, rescues autophagy flux in DMD cells. (A) Left panel : Immunofluorescence detection of MHC in human DMD cell models, DMD6 and DMD14, under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM) 72 h post stimulation. Right panel : Immunoblot analysis of p62, LC3, and Cathepsin L, in human DMD6 and DMD14 myotubes at the 72‐h point under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM). (B) DMD myotubes were transfected with <t>siRNA</t> targeting preproghrelin or siRNA‐scramble prior to induction of myogenesis for 96 h. The expression of expansion (p21, Ki‐67, fast‐MHC, slow‐MHC, myogenin), autophagy (p62, LC3, Beclin1, Bnip3, VPS34, AMBRA1) and mitochondrial homeostasis (DRP1, Parkin, TFAM, Mfn2) markers were evaluated by immunoblot analysis ( n = 3). Immunoblots are representative of the mean value. Data were expressed as the mean ± SEM obtained from intensity scans of independent experiments. * p < 0.05. (C) Immunoblot analysis of p62, LC3, Cathepsin L, pAMPK(T172), AMPK, pmTOR(S2448), mTOR, and MHC in human DMD myotubes at the 24‐h point under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM). Cells were treated with the autophagy inhibitor chloroquine (20 µM) 6 h before collection. Immunoblots are representative of the mean value. Data were expressed as the mean ± SEM obtained from intensity scans of three independent experiments *,# p < 0.05. (D) Left panel : Immunofluorescence detection of microtubule‐associated protein 1 light chain 3 isoform B (LC3B) in human DMD cell model under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM) at the 24 h point after stimulation. Cells were treated with the autophagy inhibitor chloroquine. Right panel : the changes in LC3 puncta/area from DMD myotube cells are shown. Data were expressed as mean ± SEM ( n = 3 per group). * p < 0.05. (E) Immunoblot analysis of DRP1, TFAM, Mfn2, and Pink1 in human DMD myotubes at the 24 h point under obestatin treatment (10 nM). Cells were treated with chloroquine before collection. Immunoblots are representative of the mean value. Data were expressed as the mean ± SEM ( n = 3 per group; *,# p < 0.05). (F) Quantification of ROS levels in DMD myotube cells using CellROX TM fluorescent dye. DMD myotubes were treated with obestatin (10 nM), Dexa (1 µM), or vehicle (control) for 24 h. Results are represented as variation of MFI between control and obestatin‐ or Dexa‐treated cells. Data were expressed as mean ± SEM ( n = 3 per group). * p < 0.05.
Control Nontargeting Shrna Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nontargeting+shrna/Control+shRNA+Plasmid-A/pmc12803508-356-6-11
Average 96 stars, based on 1 article reviews
control nontargeting shrna plasmid - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


Preproghrelin, and thus obestatin, rescues autophagy flux in DMD cells. (A) Left panel : Immunofluorescence detection of MHC in human DMD cell models, DMD6 and DMD14, under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM) 72 h post stimulation. Right panel : Immunoblot analysis of p62, LC3, and Cathepsin L, in human DMD6 and DMD14 myotubes at the 72‐h point under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM). (B) DMD myotubes were transfected with siRNA targeting preproghrelin or siRNA‐scramble prior to induction of myogenesis for 96 h. The expression of expansion (p21, Ki‐67, fast‐MHC, slow‐MHC, myogenin), autophagy (p62, LC3, Beclin1, Bnip3, VPS34, AMBRA1) and mitochondrial homeostasis (DRP1, Parkin, TFAM, Mfn2) markers were evaluated by immunoblot analysis ( n = 3). Immunoblots are representative of the mean value. Data were expressed as the mean ± SEM obtained from intensity scans of independent experiments. * p < 0.05. (C) Immunoblot analysis of p62, LC3, Cathepsin L, pAMPK(T172), AMPK, pmTOR(S2448), mTOR, and MHC in human DMD myotubes at the 24‐h point under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM). Cells were treated with the autophagy inhibitor chloroquine (20 µM) 6 h before collection. Immunoblots are representative of the mean value. Data were expressed as the mean ± SEM obtained from intensity scans of three independent experiments *,# p < 0.05. (D) Left panel : Immunofluorescence detection of microtubule‐associated protein 1 light chain 3 isoform B (LC3B) in human DMD cell model under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM) at the 24 h point after stimulation. Cells were treated with the autophagy inhibitor chloroquine. Right panel : the changes in LC3 puncta/area from DMD myotube cells are shown. Data were expressed as mean ± SEM ( n = 3 per group). * p < 0.05. (E) Immunoblot analysis of DRP1, TFAM, Mfn2, and Pink1 in human DMD myotubes at the 24 h point under obestatin treatment (10 nM). Cells were treated with chloroquine before collection. Immunoblots are representative of the mean value. Data were expressed as the mean ± SEM ( n = 3 per group; *,# p < 0.05). (F) Quantification of ROS levels in DMD myotube cells using CellROX TM fluorescent dye. DMD myotubes were treated with obestatin (10 nM), Dexa (1 µM), or vehicle (control) for 24 h. Results are represented as variation of MFI between control and obestatin‐ or Dexa‐treated cells. Data were expressed as mean ± SEM ( n = 3 per group). * p < 0.05.

Journal: MedComm

Article Title: Obestatin Treatment Counteracts Muscle Wasting by Reactivation of Autophagy in Duchenne Muscular Dystrophy

doi: 10.1002/mco2.70563

Figure Lengend Snippet: Preproghrelin, and thus obestatin, rescues autophagy flux in DMD cells. (A) Left panel : Immunofluorescence detection of MHC in human DMD cell models, DMD6 and DMD14, under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM) 72 h post stimulation. Right panel : Immunoblot analysis of p62, LC3, and Cathepsin L, in human DMD6 and DMD14 myotubes at the 72‐h point under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM). (B) DMD myotubes were transfected with siRNA targeting preproghrelin or siRNA‐scramble prior to induction of myogenesis for 96 h. The expression of expansion (p21, Ki‐67, fast‐MHC, slow‐MHC, myogenin), autophagy (p62, LC3, Beclin1, Bnip3, VPS34, AMBRA1) and mitochondrial homeostasis (DRP1, Parkin, TFAM, Mfn2) markers were evaluated by immunoblot analysis ( n = 3). Immunoblots are representative of the mean value. Data were expressed as the mean ± SEM obtained from intensity scans of independent experiments. * p < 0.05. (C) Immunoblot analysis of p62, LC3, Cathepsin L, pAMPK(T172), AMPK, pmTOR(S2448), mTOR, and MHC in human DMD myotubes at the 24‐h point under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM). Cells were treated with the autophagy inhibitor chloroquine (20 µM) 6 h before collection. Immunoblots are representative of the mean value. Data were expressed as the mean ± SEM obtained from intensity scans of three independent experiments *,# p < 0.05. (D) Left panel : Immunofluorescence detection of microtubule‐associated protein 1 light chain 3 isoform B (LC3B) in human DMD cell model under DM (control), DM + obestatin (10 nM), or DM + insulin (1.72 µM) at the 24 h point after stimulation. Cells were treated with the autophagy inhibitor chloroquine. Right panel : the changes in LC3 puncta/area from DMD myotube cells are shown. Data were expressed as mean ± SEM ( n = 3 per group). * p < 0.05. (E) Immunoblot analysis of DRP1, TFAM, Mfn2, and Pink1 in human DMD myotubes at the 24 h point under obestatin treatment (10 nM). Cells were treated with chloroquine before collection. Immunoblots are representative of the mean value. Data were expressed as the mean ± SEM ( n = 3 per group; *,# p < 0.05). (F) Quantification of ROS levels in DMD myotube cells using CellROX TM fluorescent dye. DMD myotubes were treated with obestatin (10 nM), Dexa (1 µM), or vehicle (control) for 24 h. Results are represented as variation of MFI between control and obestatin‐ or Dexa‐treated cells. Data were expressed as mean ± SEM ( n = 3 per group). * p < 0.05.

Article Snippet: An ON‐TARGETplus nontargeting siRNA (Dharmacon) or control nontargeting shRNA plasmid (sc‐108060; Santa Cruz Biotechnology) was used as a control for siRNA or shRNA experiments.

Techniques: Immunofluorescence, Control, Western Blot, Transfection, Expressing